Related Experiment Videos
Indications and choice of antihypertensive drugs (cont'd): British recommendations
Prescrire International
|November 7, 2000
Insights
Antihypertensive monotherapy is recommended for patients with high blood pressure (systolic ≥ 160 mm Hg or diastolic ≥ 100 mm Hg) and no other cardiovascular risks. This treatment approach aims to manage hypertension effectively.
Area of Science:
- Cardiology
- Internal Medicine
- Pharmacology
Background:
- Hypertension is a major risk factor for cardiovascular disease.
- Optimal timing for initiating antihypertensive treatment is crucial for patient outcomes.
Purpose of the Study:
- To define the threshold for initiating antihypertensive monotherapy in patients without additional cardiovascular risk factors.
Main Methods:
- Analysis of patient data to identify blood pressure thresholds.
- Review of clinical guidelines and evidence for antihypertensive treatment initiation.
Main Results:
- Antihypertensive monotherapy should be initiated when systolic blood pressure is consistently ≥ 160 mm Hg.
- Alternatively, treatment should commence if diastolic blood pressure is consistently ≥ 100 mm Hg.
Conclusions:
- Establishing clear blood pressure targets for treatment initiation is essential.
- Monotherapy is indicated as a first-line approach in specific hypertensive patient groups.
Abstract:
(1) In the absence of other cardiovascular risk factors, antihypertensive monotherapy should be started in patients with a systolic blood pressure of at least 160 mm Hg or a diastolic pressure of at least 100 mm Hg at repeated measurements.